Gerresheimer is trading at €25.60 (+4.49%) as the stock rebounds from a volatile stretch triggered by execution risks and a recent analyst downgrade.
- Jefferies downgraded the stock to Hold from Buy on May 19, setting a €26.80 price target while citing integration concerns regarding the Bormioli Pharma acquisition.
- The price action follows a period of investor pressure linked to delayed financial disclosures and broader caution in the European market.